Using preclinical models, we have recently found that ELK1, a transcriptional factor that activates downstream targets, includingc-fosproto-oncogene, induces bladder cancer outgrowth. Here, we immunohistochemically determined the expression status of phospho-ELK1, an activated form of ELK1, in upper urinary tract urothelial carcinoma (UUTUC).